SATURDAY JULY 9 |
|
2000-2200 |
Concurrent Special Interest Group (SIG) Sessions
|
|
|
MONDAY JULY 11 |
|
2000-2200 |
Concurrent Special Interest Group (SIG) Sessions |
Gynecological Pathology Special Interest Group
Saturday July 9, 2000-2200
Objectives:
At the end of this session, participants will be able to:
- Identify those results from The Cancer Genome Atlas that make it possible to now offer a genomic-based classification of endometrial carcinoma.
- Describe the clinical and pathological features of endometrial cancers with POLE mutations.
- List the molecular features that define the dedifferentiated/undifferentiated group of endometrial carcinomas.
2000-2005 |
Welcome |
2005-2050 |
Towards molecular subclassification of endometrial carcinoma Lien Hoang, Memorial Sloan Kettering Cancer Center |
2050-2100 |
Discussion |
2100-2120 |
POLE mutant endometrial carcinomas: histopathological features and outcomes Mary Kinloch, University of Saskatchewan |
2120-2130 |
Discussion |
2130-2155 |
Dedifferentiated/Undifferentiated endometrial carcinoma: the molecular basis of an aggressive endometrial carcinoma variant distinct from serous or clear cell carcinoma Chenghan Lee, University of Alberta |
2155-2200 |
Discussion |
Nephropathology Special Interest Group
Saturday July 9, 2000-2200
1. |
Approval of agenda |
2. |
Approval of minutes, June 20, 2015 |
3. |
Website |
4. |
Guidelines |
5. |
Collaboration with CSN
|
6. |
Other business
|
7. |
Interesting cases |
8. |
Next meeting: Charlottetown, 2017 |
9. |
Adjournment |
Canadian Network of Uropathology
Monday July 11, 2000-2200
2000-2015 |
Spindle Cell Tumors of the Kidney George M. Yousef, University of Toronto |
2015-2020 |
Discussion |
2020-2035 |
The Gamut of Neuroendocrine Differentiation in Prostate Cancer Theodorus H. Van der Kwast, Princess Margaret Cancer Center, University Health Network |
2035-2040 |
Discussion |
2040-2055 |
New Molecular Subtypes of Bladder Cancer David Berman, Queen’s University, Queen’s Cancer Research Institute |
2055-2100 |
Discussion |
2100-2110 |
Break |
2110-2125 |
What is new in Testis Pathology? Asli Yilmaz , Calgary Laboratory Services |
2125-2130 |
Discussion |
2130-2200 |
Open CNUP Discussions |
Evidence Based Medicine Special Interest Group – Bits and Bites of Evidence-Based Medicine for Practicing Pathologist
Monday July 11, 2000-2200
The Diagnostic Accuracy Question and PIRATES Mary Anne Brett, McMaster University |
Do We Understand Diagnostic Accuracy? Nick Myles, Providence Health Care / University of British Columbia |
Accuracy vs Reproducibility: If you don’t agree, does that mean you are wrong? Mary Anne Brett, McMaster University |
How Do I Take a Section of THAT?!? – Medical Devices, Pathology, and Quality Assurance Michael A. Seidman, Providence Health Care / University of British Columbia |
Number Needed To Harm: A case of radiation induces angiosarcoma Kennry Chiu, University of British Columbia |
Making Likelihood Ratios of Use: Bethesda System for Thyroid Cytology Emilia Todorovic, University of British Columbia |
Libre Pathology: Disseminating Evidence-Based Pathology Information Michael Bonert, McMaster University |
Expanded Evidence: Levels of Truth J. Fergall Magee, University of Saskatchewan |
All CAP-ACP Members, irrespective whether they are SIG members or not, are welcome to attend!
General Pathology Special Interest Group
Monday July 11, 2000-2200
The discussion will focus on planning for the development of a new section for GP and to solicit feedback from interested parties as to how to structure this new group.
Download the Terms of Reference of the New GP Section